Demerol Articles
Caraco expects $35M revenues in 2003
24 February 2003
Caraco gets generic Demerol approval in USA
19 August 2002
Significant Increases For US Drug Firms In 1996
3 February 1997
BARR LABS HAS 24 PRODUCTS SUSPENDED
15 February 1993
Showing 1-4 of 4 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
